Showing results (21-30 of 55) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2022
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration CohortsPaul M Barr, Alessandra Tedeschi, William G Wierda, et al.Haematologica|January 19, 2023
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergyFrancesca Arruga, Marta Rubin, Despoina Papazoglou, et al.Cell Genomics|October 11, 2025
Co-mapping clonal and transcriptional heterogeneity in somatic evolution via GoT-MultiMinwoo Pak, Mirca S Saurty-Seerunghen, Kellie Wise, et al.Haematologica|March 18, 2021
Phase II study of acalabrutinib in ibrutinib-intolerant patients with relapsed/refractory chronic lymphocytic leukemiaKerry A Rogers, Philip A Thompson, John N Allan, et al.Blood|January 29, 2021
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse modelsTiziana Vaisitti, Francesca Arruga, Nicoletta Vitale, et al.American Journal of Hematology|August 23, 2021
Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.Blood Advances|July 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemiaJorge J Castillo, Alberto Guijosa, John N Allan, et al.Cellular and Molecular Life Sciences : CMLS|April 9, 2025
Complementary approaches define the metabolic features that accompany Richter syndrome transformationGiulia Omezzolli, Andrea Iannello, Francesco E Vallone, et al.American Journal of Hematology|February 12, 2019
Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myelomaPeter A Forsberg, Adriana C Rossi, Angelique Boyer, et al.Cancer|April 9, 2026
Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025Alexey V Danilov, Catherine C Coombs, Tycel Phillips, et al.Pageof 6